VYOME HOLDINGS, INC. Additional Paid in Capital, Common Stock
VYOME HOLDINGS, INC. (HIND) had Additional Paid in Capital, Common Stock of $95.37 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-12
- 2026-06-30: Additional Paid in Capital, Common Stock $95.37M.
- 2025-12-31: Additional Paid in Capital, Common Stock $90.08M.
- 2021-03-31: Additional Paid in Capital, Common Stock $199.02M.
- 2020-12-31: Additional Paid in Capital, Common Stock $189.42M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $95.37M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $90.08M 10-Q · filed 2026-08-12 | |
| 2021-03-31 | $199.02M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $189.42M 10-Q · filed 2021-05-12 | |
| 2020-09-30 | $189.35M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $189.05M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $188.75M 10-Q · filed 2020-06-19 | |
| 2019-12-31 | $188.27M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $187.57M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $172.16M 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $163.54M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $161.86M 10-K · filed 2020-02-27 | $161.84M 10-K · filed 2019-02-22 |
| 2018-09-30 | $160.13M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $149.28M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $147.91M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $146.47M 10-K · filed 2019-02-22 | |
| 2017-09-30 | $144.76M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $142.31M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $141.42M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $140.90M 10-K · filed 2018-03-05 | |
| 2016-09-30 | $2.02M 10-Q · filed 2016-11-10 | |
| 2015-12-31 | $1.00M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |